Next Article in Journal
5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
Previous Article in Journal
DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes
Previous Article in Special Issue
A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment
Cancers 2010, 2(3), 1705-1716; doi:10.3390/cancers2031705
Review

Aberrant Crypt Foci: The Case for Inclusion as a Biomarker for Colon Cancer

* ,
 and
Received: 28 August 2010; Accepted: 14 September 2010 / Published: 16 September 2010
(This article belongs to the Special Issue Biomarkers: Oncology Studies)
View Full-Text   |   Download PDF [269 KB, uploaded 16 September 2010]   |   Browse Figure
Abstract: Aberrant crypt foci (ACF) are one of the earliest histopathological manifestations of colon cancer. In this review, we critically present the molecular, cellular, histopathological, and chemopreventive evidence that ACF are relevant biomarkers for colon cancer. The laboratory and clinical evidence are highly suggestive that ACF are in the pathway leading to colon cancer, but not all ACF will do so. The possible fate and outcome of ACF in the progression toward colon cancer may be dependent on a number of features that define their predictive power for the prevention or progression of cancer.
Keywords: aberrant crypt foci; biomarker; colon cancer; chemoprevention aberrant crypt foci; biomarker; colon cancer; chemoprevention
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Wargovich, M.J.; Brown, V.R.; Morris, J. Aberrant Crypt Foci: The Case for Inclusion as a Biomarker for Colon Cancer. Cancers 2010, 2, 1705-1716.

AMA Style

Wargovich MJ, Brown VR, Morris J. Aberrant Crypt Foci: The Case for Inclusion as a Biomarker for Colon Cancer. Cancers. 2010; 2(3):1705-1716.

Chicago/Turabian Style

Wargovich, Michael J.; Brown, Vondina R.; Morris, Jay. 2010. "Aberrant Crypt Foci: The Case for Inclusion as a Biomarker for Colon Cancer." Cancers 2, no. 3: 1705-1716.


Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert